[HTML][HTML] Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and …
HT Liu, F Li, WY Wang, XJ Li, YM Liu… - Texas Heart Institute …, 2010 - ncbi.nlm.nih.gov
HT Liu, F Li, WY Wang, XJ Li, YM Liu, RA Wang, WY Guo, HC Wang
Texas Heart Institute Journal, 2010•ncbi.nlm.nih.govEndothelial-cell function is important in the healing of damaged endothelium after
percutaneous coronary artery damage. In 3 different animal models, we sought to determine
whether rapamycin (sirolimus) affects the proliferation and migration of endothelial cells and
endothelial progenitor cells.
percutaneous coronary artery damage. In 3 different animal models, we sought to determine
whether rapamycin (sirolimus) affects the proliferation and migration of endothelial cells and
endothelial progenitor cells.
Abstract
Endothelial-cell function is important in the healing of damaged endothelium after percutaneous coronary artery damage. In 3 different animal models, we sought to determine whether rapamycin (sirolimus) affects the proliferation and migration of endothelial cells and endothelial progenitor cells.
ncbi.nlm.nih.gov